Carbon-14 Bioconjugation: Peptides and Antibody Drug Conjugates
Almac explains how the synergy between their peptide and protein technology and radiolabeling groups can enable the manufacture of carbon-14 labeled peptides and antibody-drug conjugates (ADCs) to meet customer requirements.
View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.
